731 related articles for article (PubMed ID: 25688915)
1. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
Sauvageau VM; Roy JP; Langlois M; Macoir J
Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
[TBL] [Abstract][Full Text] [Related]
2. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
[TBL] [Abstract][Full Text] [Related]
3. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
[TBL] [Abstract][Full Text] [Related]
4. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
Wight S; Miller N
Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
[TBL] [Abstract][Full Text] [Related]
5. Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria.
Wenke RJ; Cornwell P; Theodoros DG
Int J Speech Lang Pathol; 2010 Jun; 12(3):203-20. PubMed ID: 20433339
[TBL] [Abstract][Full Text] [Related]
6. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
[TBL] [Abstract][Full Text] [Related]
7. Spectral/Cepstral Analyses of Phonation in Parkinson's Disease before and after Voice Treatment: A Preliminary Study.
Alharbi GG; Cannito MP; Buder EH; Awan SN
Folia Phoniatr Logop; 2019; 71(5-6):275-285. PubMed ID: 31117110
[TBL] [Abstract][Full Text] [Related]
8. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
Tjaden K; Wilding GE
J Speech Lang Hear Res; 2004 Aug; 47(4):766-83. PubMed ID: 15324285
[TBL] [Abstract][Full Text] [Related]
9. Changes in vowel articulation with subthalamic nucleus deep brain stimulation in dysarthric speakers with Parkinson's disease.
Martel Sauvageau V; Macoir J; Langlois M; Prud'Homme M; Cantin L; Roy JP
Parkinsons Dis; 2014; 2014():487035. PubMed ID: 25400977
[TBL] [Abstract][Full Text] [Related]
10. Effects of an intensive voice treatment on articulatory function and speech intelligibility in children with motor speech disorders: A phase one study.
Langlois C; Tucker BV; Sawatzky AN; Reed A; Boliek CA
J Commun Disord; 2020; 86():106003. PubMed ID: 32505858
[TBL] [Abstract][Full Text] [Related]
11. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.
Ramig LO; Sapir S; Countryman S; Pawlas AA; O'Brien C; Hoehn M; Thompson LL
J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):493-8. PubMed ID: 11561033
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Clear Speech on the Perceptual and Acoustic Properties of Fricative-Vowel Sequences in Speakers With Dysarthria.
Martel-Sauvageau V; Breton M; Chabot A; Langlois M
Am J Speech Lang Pathol; 2021 Jun; 30(3S):1410-1428. PubMed ID: 33784184
[TBL] [Abstract][Full Text] [Related]
13. Formant centralization ratio: a proposal for a new acoustic measure of dysarthric speech.
Sapir S; Ramig LO; Spielman JL; Fox C
J Speech Lang Hear Res; 2010 Feb; 53(1):114-25. PubMed ID: 19948755
[TBL] [Abstract][Full Text] [Related]
14. Intensive treatment of dysarthria secondary to stroke.
Mahler LA; Ramig LO
Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
[TBL] [Abstract][Full Text] [Related]
15. An acoustic study of coarticulation in dysarthric speakers with Parkinson disease.
Tjaden K
J Speech Lang Hear Res; 2000 Dec; 43(6):1466-80. PubMed ID: 11193966
[TBL] [Abstract][Full Text] [Related]
16. Effect of rate reduction and increased loudness on acoustic measures of anticipatory coarticulation in multiple sclerosis and Parkinson's disease.
Tjaden K; Wilding GE
J Speech Lang Hear Res; 2005 Apr; 48(2):261-77. PubMed ID: 15989391
[TBL] [Abstract][Full Text] [Related]
17. Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease.
Cannito MP; Suiter DM; Beverly D; Chorna L; Wolf T; Pfeiffer RM
J Voice; 2012 Mar; 26(2):214-9. PubMed ID: 22209057
[TBL] [Abstract][Full Text] [Related]
18. Vowel acoustics in Parkinson's disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions.
Tjaden K; Lam J; Wilding G
J Speech Lang Hear Res; 2013 Oct; 56(5):1485-502. PubMed ID: 23838989
[TBL] [Abstract][Full Text] [Related]
19. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
[TBL] [Abstract][Full Text] [Related]
20. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
